Xilio Therapeutics (XLO) Prepaid Assets (2020 - 2026)

Xilio Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $3.9 million in Q1 2026.

• Quarterly Prepaid Assets fell 6.13% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 6.13% YoY) and the FY2025 annual result came in at $2.5 million, down 49.5% from the prior year.
• Prepaid Assets grew to $3.9 million in Q1 2026 per XLO's latest filing, from $2.5 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $5.2 million in Q1 2024 and troughed at $2.0 million in Q3 2024.
• A 5-year average of $3.6 million and a median of $3.6 million in 2022 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2023 and 2024: Prepaid Assets jumped 48.47% in 2023, then tumbled 56.46% in 2024.
• Over 5 years, Prepaid Assets stood at $4.1 million in 2022, then decreased by 16.74% to $3.4 million in 2023, then jumped by 44.41% to $4.9 million in 2024, then plunged by 49.5% to $2.5 million in 2025, then soared by 55.21% to $3.9 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $3.9 million, $2.5 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.